Current Status of HIV-1 Vaccines
HIV-1 infection and its progression to AIDS remains a significant global health challenge, particularly for low-income countries. Developing a vaccine to prevent HIV-1 infections has proven to be immensely challenging with complex biological acquisition and infection, unforeseen clinical trial disap...
Main Authors: | Anna Hargrave, Abu Salim Mustafa, Asma Hanif, Javed H. Tunio, Shumaila Nida M. Hanif |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/9/1026 |
Similar Items
-
What Has 30 Years of HIV Vaccine Research Taught Us?
by: José Esparza
Published: (2013-10-01) -
HIV Vaccination: A Roadmap among Advancements and Concerns
by: Maria Trovato, et al.
Published: (2018-04-01) -
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
by: Susan Zolla-Pazner, et al.
Published: (2014-11-01) -
Is an HIV vaccine possible?
by: Nancy A. Wilson, et al. -
The Increase of the Magnitude of Spontaneous Viral Blips in Some Participants of Phase II Clinical Trial of Therapeutic Optimized HIV DNA Vaccine Candidate
by: Ekaterina Akulova, et al.
Published: (2019-08-01)